ReviewCells2022
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia.
Javier Muñoz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCells2022
Javier Muñoz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.